Pablo Vidal
Impact in
-
- Nosocomial Infections in ICU
-
- Antibiotic Use and Resistance
Papers in
-
- COVID-19 Clinical Research Studies 22
-
- Advanced Glycation End Products research 6
- Co-authors
- Emili Dı́az (10 shared papers)Paula Ramirez (6 shared papers)Ignacio Martín‐Loeches (6 shared papers)Emilio Maseda (3 shared papers)Ricard Ferrer (3 shared papers)Xavier Nuvials (6 shared papers)Alejandro Rodriguez Oviedo (4 shared papers)Mercedes Nieto (4 shared papers)
- Journals
- Critical Care (6 papers)Intensive Care Medicine (6 papers)Antibiotics (4 papers)Acta Ophthalmologica (2 papers)Annals of Intensive Care (2 papers)
- Partner nations
- SpainIrelandUnited Kingdom
In The Last Decade
Pablo Vidal
57 papers receiving 914 citations
Peers
Comparison fields: 5 of 85
- Critical Care and Intensive Care Medicine 116
- Applied Microbiology and Biotechnology 57
- Clinical Biochemistry 64
- Infectious Diseases 202
- Molecular Medicine 71
Countries citing papers authored by Pablo Vidal
This map shows the geographic impact of Pablo Vidal's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pablo Vidal with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pablo Vidal more than expected).
Fields of papers citing papers by Pablo Vidal
This network shows the impact of papers produced by Pablo Vidal. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pablo Vidal. The network helps show where Pablo Vidal may publish in the future.
Co-authors
The 25 scholars most cited alongside Pablo Vidal, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 62 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2020 | 136 | |
| 2 | 1986 | 62 | |
| 3 | 2017 | 55 | |
| 4 | 2020 | 49 | |
| 5 | Current aspects in sepsis approach. Turning things around. | 2018 | 42 |
| 6 | 2022 | 42 | |
| 7 | 2014 | 35 | |
| 8 | 2022 | 26 | |
| 9 | 2022 | 26 | |
| 10 | 2023 | 25 | |
| 11 | 2021 | 24 | |
| 12 | 2022 | 24 | |
| 13 | 1993 | 21 | |
| 14 | 2021 | 21 | |
| 15 | 2020 | 19 | |
| 16 | 2022 | 18 | |
| 17 | 2023 | 18 | |
| 18 | 2021 | 17 | |
| 19 | 2022 | 17 | |
| 20 | 2023 | 17 |
About Pablo Vidal
Pablo Vidal is a scholar working on Infectious Diseases, Clinical Biochemistry, Molecular Medicine, Critical Care and Intensive Care Medicine and Applied Microbiology and Biotechnology, having authored 62 papers that have together received 950 indexed citations. Recurring topics across this work include COVID-19 Clinical Research Studies (22 papers), Sepsis Diagnosis and Treatment (10 papers), Respiratory Support and Mechanisms (7 papers), Advanced Glycation End Products research (6 papers), Antibiotic Resistance in Bacteria (6 papers), Nosocomial Infections in ICU (5 papers), Antibiotic Use and Resistance (4 papers) and Bacterial biofilms and quorum sensing (3 papers). The work is most often cited by research in Critical Care and Intensive Care Medicine (116 citations), Applied Microbiology and Biotechnology (57 citations), Clinical Biochemistry (64 citations), Infectious Diseases (202 citations) and Molecular Medicine (71 citations). Pablo Vidal has collaborated with scholars based in Spain, Ireland and United Kingdom. Frequent co-authors include Emili Dı́az, Paula Ramirez, Ignacio Martín‐Loeches, Emilio Maseda, Ricard Ferrer, Xavier Nuvials, Alejandro Rodriguez Oviedo, Mercedes Nieto, Rafael Zaragoza and Marcío Borges-Sa. Their work appears in journals such as Critical Care, Intensive Care Medicine, Antibiotics, Acta Ophthalmologica and Annals of Intensive Care.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.